MoneyWorks4Me

Raymed Labs - Quaterly Results

07 Feb 2023 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended December 2022. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended December 2022 is Rs. -0.16 millions as compared to Net Loss of Rs. -0.15 millions of corresponding quarter ended December 2021 Operating profit Margin for the quarter ended December 2022 further decreased to -0.15% as compared to -0.14% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00
PBIDT -0.15 -0.14 7.14 -0.88 -0.33 166.67 -0.77 -0.63 22.22
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.15 -0.14 7.14 -0.88 -0.33 166.67 -0.77 -0.63 22.22
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.05 0.06 -16.67
PBT -0.16 -0.15 6.67 -0.91 -0.36 152.78 -0.82 -0.69 18.84
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.16 -0.15 6.67 -0.91 -0.36 152.78 -0.82 -0.69 18.84
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Uflex 663.05
EPL 238.55
AGI Greenpac 803.90
Huhtamaki India 242.40
TCPL Packaging 4107.35
View more..